Diagnosing Health-Care Stocks


Published On: August 18th, 2009

Scott Migliori, co-chief investment officer of U.S. equities at RCM, talks about health-related stocks that are poised to do well regardless of how health-care reform plays out. Jonathan Burton reports.

Here is the original: 
Diagnosing Health-Care Stocks/a>

STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!

Stop Panic Attacks
The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.

try-now

YouTube Video



Loading...


Did You Know Did you know:


In 2003, HIV and AIDS was the leading cause of death for African-American women between 25 and 34 years of age. The rate of HIV diagnosis among African-American women was 25 times that of white women, and African-American men were eight times more likely than their white counterparts to be diagnosed with HIV

Related Posts

  • News Hub: Time to Sell Health-Care Stocks?
    While pundits were surprised by Republican Scott Brown’s Massachusetts victory, Mr. Market wasn’t ..
  • Diagnosing Harry Potter
    The Harry Potter books and films have enjoyed enormous popularity in part because they portray key themes and stages of adolescence. Health columnist Melinda Beck reports. ..
  • Hot Stocks: Pharmaceuticals
    Drug companies’ stocks climb Monday after Abbott Laboratories says it will buy the pharmaceutical unit of Solvay for about $7 billion. MarketWatch’s Christopher Hinton reports. ..
  • GE, Brain Imaging and Diagnosing Parkinson’s Disease
    Parkinson’s disease , like Alzheimer’s and some other progressive brain diseases, is difficult to diagnose because there’s no blood or lab test to determine who has it. Now, GE is hoping the FDA will approve its chemical for brain imaging, which the company says may help docs rule out the possibility that a patient has..
  • Diabetes Roundup: Drugs, Stents and Stocks
    The American Diabetes Association’s Scientific Sessions were center stage this weekend in New Orleans. A few items of note: Stents and certain branded drugs were no better at preventing death in some diabetic patients than a regimen of older, cheaper drugs, according to a randomized, federally funded study of more than 2,000 patients, the WSJ..
  • Health Reform: Individual Mandates, High Stakes for Obama
    Here are a few stories on health-care reform that caught our eye this morning: One thread common to all three major bills under consideration in Congress is a mandate that would for the first time require every American carry health insurance, just like the requirement that all drivers have car insurance, notes the Washington Post..
Leave a comment
Comments are closed.
« More Training for Soldiers, With Feeling How Do You Ask Your Doctor if He Gets Paid by the Drug Industry? »